Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures-Reference-Cited by-同舟云学术

Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures

Published:2022-03 Issue: Volume:24 Page:230-248
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Stepanenko Aleksei A.,Sosnovtseva Anastasiia O.,Valikhov Marat P.,Chernysheva Anastasia A.,Cherepanov Sergey A.,Yusubalieva Gaukhar M.,Ruzsics Zsolt,Lipatova Anastasiia V.,Chekhonin Vladimir P.

Funder

Russian Foundation for Basic Research

Russian Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference75 articles.

1. Recent advances in oncolytic virotherapy and Immunotherapy for glioblastoma: a glimmer of hope in the search for an effective therapy?;Stepanenko;Cancers (Basel),2018

2. A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy;Stepanenko;Gene,2018

3. Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: focus on fiber chimerism and mosaicism, hexon and pIX;Stepanenko;Virus Res.,2018

4. Clinical trials using oncolytic viral therapy to treat adult glioblastoma: a progress report;Lu;Neurosurg. Focus,2021

5. Viral therapies for glioblastoma and high-grade gliomas in adults: a systematic review;Wang;Neurosurg. Focus,2021

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo dendritic cell reprogramming for cancer immunotherapy;Science;2024-09-05

2. A cancer immunotherapy modality based on dendritic cell reprogrammingin vivo;2024-07-11

3. An engineered TNFR1-selective human lymphotoxin-alpha mutant delivered by an oncolytic adenovirus for tumor immunotherapy;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06

4. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

5. Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant Breast Cancer Stem Cells;Viruses;2024-04-05